4.7 Editorial Material

3D Printing of Pharmaceuticals and Drug Delivery Devices

Journal

PHARMACEUTICS
Volume 12, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/pharmaceutics12030266

Keywords

3D printing; bioprinting; additive manufacturing; computer-aided design (CAD); drug delivery; personalized medicine; pharmaceutics

Ask authors/readers for more resources

The process of 3D printing (3DP) was patented in 1986; however, the research in the field of 3DP did not become popular until the last decade. There has been an increasing research into the areas of 3DP for medical applications for fabricating prosthetics, bioprinting and pharmaceutics. This novel method allows the manufacture of dosage forms on demand, with modifications in the geometry and size resulting in changes to the release and dosage behaviour of the product. 3DP will allow wider adoption of personalised medicine due to the diversity and simplicity to change the design and dosage of the products, allowing the devices to be designed specific to the individual with the ability to alternate the drugs added to the product. Personalisation also has the potential to decrease the common side effects associated with generic dosage forms. This Special Issue Editorial outlines the current innovative research surrounding the topic of 3DP, focusing on bioprinting and various types of 3DP on applications for drug delivery as well advantages and future directions in this field of research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Instruments & Instrumentation

3D bioprinted scaffolds for diabetic wound-healing applications

Katie Glover, Essyrose Mathew, Giulia Pitzanti, Erin Magee, Dimitrios A. Lamprou

Summary: The treatment strategy for diabetic foot ulcer (DFU) is complex, requires multiple therapeutic approaches, and often results in amputation. Bioprinting technologies show innovative potential in fabricating antibiotic scaffolds for DFU treatment.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Article Instruments & Instrumentation

Optimization of FDM 3D printing process parameters to produce haemodialysis curcumin-loaded vascular grafts

Sara Basile, Essyrose Mathew, Ida Genta, Bice Conti, Rossella Dorati, Dimitrios A. Lamprou

Summary: This study validated an optimized FDM 3D printing method for the manufacturing of personalized medical implants, particularly fistulas. Different types of filaments were produced using hot melt extrusion, and the printed fistulas were characterized using various physicochemical analysis methods. The results demonstrated that TPU material is suitable for 3D printing and successful drug loading. Drug release testing showed sustained release, meeting the requirements for implants in the patient's body.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Article Toxicology

Impact of solid lipid nanoparticles on 3T3 fibroblasts viability and lipid profile: The effect of curcumin and resveratrol loading

Antonella Rosa, Mariella Nieddu, Giulia Pitzanti, Rosa Pireddu, Francesco Lai, Maria Cristina Cardia

Summary: This study investigated the impact of different types of solid lipid nanoparticles (SLN), both empty and loaded with curcumin and resveratrol, on cell viability and lipid metabolism in 3T3 fibroblasts. The results showed that empty SLN did not exhibit cytotoxicity, while curcumin-loaded and resveratrol-loaded SLN reduced cell viability. Additionally, the lipid content and encapsulated drug in the SLN affected cell lipid metabolism.

JOURNAL OF APPLIED TOXICOLOGY (2023)

Article Pharmacology & Pharmacy

Development of 3D-printed subcutaneous implants using concentrated polymer/drug solutions

Camila J. Picco, Emilia Utomo, Andrea McClean, Juan Dominguez-Robles, Qonita Kurnia Anjani, Fabiana Volpe-Zanutto, Peter E. McKenna, Jonathan G. Acheson, Dessislava Malinova, Ryan F. Donnelly, Eneko Larraneta

Summary: Implantable drug-eluting devices have the potential to improve treatment of chronic conditions by providing sustained therapeutic effects and reducing pill burden for patients. The use of modern technologies like 3D printing allows for the production of customizable devices. In this study, subcutaneous implants loaded with olanzapine were formulated using the robocasting technique and demonstrated sustained drug release over a period of 200 days.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Correction Pharmacology & Pharmacy

Development of intranasal implantable devices for schizophrenia treatment (Vol624, 122061 2021)

Emilia Utomo, Juan Dominguez-Robles, Natalia Moreno-Castellanos, Sarah A. Stewart, Camila J. Picco, Qonita Kurnia Anjani, Jon Ander Simon, Ivan Penuelas, Ryan F. Donnelly, Eneko Larraneta

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

3D-printed long-acting 5-fluorouracil implant to prevent conjunctival fibrosis in glaucoma

Nicole Ioannou, Jinyuan Luo, Mengqi Qin, Matteo Di Luca, Essyrose Mathew, Aristides D. Tagalakis, Dimitrios A. Lamprou, Cynthia Yu-Wai-Man

Summary: A sustained release 5-FU implant composed of PCL and CS was fabricated using 3D printing technology for preventing conjunctival fibrosis after glaucoma surgery. The implant released 5-FU steadily over 8 weeks and effectively suppressed fibroblast contractility. It exhibited biocompatibility, smooth surface, and degradability.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

The manufacturing of 3D-printed microfluidic chips to analyse the effect upon particle size during the synthesis of lipid nanoparticles

Edward Weaver, Essyrose Mathew, Jay Caldwell, Andrew Hooker, Shahid Uddin, Dimitrios A. Lamprou

Summary: In this study, a UV LCD printer was used to produce microfluidic chips for liposomal synthesis, and the limitations of UV LCD printing in terms of resolution and print speed optimization were tested. By varying channel parameters, the essential properties for optimal liposomal formulation were investigated, and liposomes with sizes of approximately 120 nm and polydispersity index values of <= 0.12 were successfully synthesized. The influence of total flow rates and lipid choice on microfluidic setup optimization was also investigated in depth.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

Drug loaded implantable devices to treat cardiovascular disease

Masoud Adhami, Niamh K. Martin, Ciara Maguire, Aaron J. Courtenay, Ryan F. Donnelly, Juan Dominguez-Robles, Eneko Larraneta

Summary: Cardiovascular diseases are the leading cause of death globally. Drug eluting implants, that provide accurate drug release and minimize adverse side effects, have the potential for significant advancements in the treatment of these diseases.

EXPERT OPINION ON DRUG DELIVERY (2023)

Article Pharmacology & Pharmacy

Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma-a systematic literature review

Beata-Maria Benko, Dimitrios. A. A. Lamprou, Anna Sebestyen, Romana Zelko, Istvan Sebe

Summary: Glioblastoma is a challenging CNS tumor, and the anti-alcoholism drug disulfiram (DS) has potential anticancer activity that could be used against GB. However, there are limitations in delivering DS to the brain-tumor tissue for effective treatment.

EXPERT OPINION ON DRUG DELIVERY (2023)

Article Chemistry, Multidisciplinary

Hydrogel-forming microarray patch mediated transdermal delivery of tetracycline hydrochloride

Li Zhao, Lalitkumar K. Vora, Stephen A. Kelly, Linlin Li, Eneko Larraneta, Helen O. McCarthy, Ryan F. Donnelly

Summary: Antibiotic resistance is a serious health problem and is expected to worsen in the future. Researchers have developed a hydrogel-forming microarray patch system that can deliver antibiotics in a sustained manner.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Pharmacology & Pharmacy

Development of 3D-printed vaginal devices containing metronidazole for alternative bacterial vaginosis treatment

Emilia Utomo, Juan Dominguez-Robles, Qonita Kurnia Anjani, Camila J. Picco, Anna Korelidou, Erin Magee, Ryan F. Donnelly, Eneko Larraneta

Summary: Bacterial vaginosis (BV) is an abnormal condition caused by changes in the vaginal microbiota. Current treatment involves the use of antibiotics, but frequent application is needed. This research proposes a prolonged release of metronidazole (MTZ) using biodegradable and biocompatible polymers in the form of intravaginal devices, which can reduce the frequency of administration.

INTERNATIONAL JOURNAL OF PHARMACEUTICS-X (2023)

Article Instruments & Instrumentation

Clopidogrel-loaded vascular grafts prepared using digital light processing 3D printing

Masoud Adhami, Camila J. Picco, Usanee Detamornrat, Qonita K. Anjani, Victoria A. Cornelius, Pamela Robles-Martinez, Andriana Margariti, Ryan F. Donnelly, Juan Dominguez-Robles, Eneko Larraneta

Summary: Cardiovascular diseases are a leading cause of death worldwide and significantly impact quality of life. 3D-printed biodegradable vascular grafts loaded with a drug called clopidogrel were developed using digital light processing technology. These grafts provide sustained drug release, reduce platelet deposition, and create a supportive environment for cellular attachment, viability, and growth.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

No Data Available